The Committee for Veterinary Medicinal Products (CVMP) recently finished its conference, which focused on enhancing animal health and welfare from July 11 to 13, 2023. The approval of a new veterinary medical treatment, demonstrating its safety and efficacy in treating a specific animal condition, was one of the primary highlights.
Concerns about pharmacovigilance were also raised, highlighting the significance of monitoring and reporting adverse effects to guarantee product safety.
The forum also stressed the need for legislation and procedures to be harmonized in order to improve access to veterinary pharmaceutical goods inside the European Union and stimulate worldwide collaboration in the field. Overall, the CVMP's focus to promoting animal healthcare and its recent accomplishments indicate their commitment to developing veterinary medicine and enhancing animal well-being.